CrushSCI.com
Journal Selection & Manuscript Polishing Services
Annals of Hepatology journal cover Medicine
Back to journal directory

Review Cycle Records

Annals of Hepatology

Elsevier SCIE OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q1
82.9Average days
72.5Median days
36Fastest days
201Longest days
3962025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

88 days

The role of inpatient palliative care consultation in end-stage liver disease: Too little, too late?

AuthorsNeha Wadhavkar; Joao Filipe G. Monteiro; Kanika Malani; Yousef Elfanagely; Kittichai Promrat

AffiliationsDepartment of Internal Medicine, The Warren Alpert Medical School of Brown University, Providence, RI, United States; Division of Gastroenterology, The Warren Alpert Medical School of Brown University, Providence, RI, United States; The Warren Alpert Medical School of Brown University, Providence, RI, United States; Section of Gastroenterology, Providence VA Medical Center, Providence, RI, United States

Source PDF DOI Publisher page
55 days

Clinical features, treatment strategies and outcomes of hepatocellular carcinoma in association with type 1 Abernethy malformation: an evaluation of a pooled case series

AuthorsFred Ahmadi; Vatsal Khanna; Leonid Shamban

AffiliationsDepartment of Internal Medicine, Henry Ford Providence Hospital, Southfield, MI, United States; Division of Gastroenterology and Hepatology, Henry Ford Providence Hospital, Southfield, MI, United States

Source PDF DOI Publisher page
36 days

Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradication

AuthorsYen-Chun Liu; Te-Sheng Chang; Chi-Yi Chen; Ya-Ting Cheng; Yi-Cheng Chen; Yi-Chung Hsieh; Wen-Juei Jeng; Chun-Yen Lin; Rong-Nan Chien; Dar-In Tai; I-Shyan Sheen

AffiliationsDepartment of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou branch, Taiwan; College of Medicine, Chang Gung University, Taiwan; Division of Hepatology and Gastroenterology, Department of Internal Medicine, Chang Gung Memorial Hospital, Chiayi, Taiwan; Department of Internal Medicine, Chia-Yi Christian Hospital, Chiayi, Taiwan

Source PDF DOI Publisher page
201 days

Association between antihypertensive medications and hepatocellular carcinoma risk in individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) without cirrhosis

AuthorsHao-Chien Hung; Po-Jung Hsu; Yin Lai; Wei-Chen Lee; Chen-Fang Lee

AffiliationsDivision of Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Taoyuan, Taiwan; Chang-Gung University College of Medicine, Taoyuan, Taiwan; Division of General Surgery, Shuang-Ho Hospital, Taipei, Taiwan; Taipei Medical University, Taipei, Taiwan

Source PDF DOI Publisher page
56 days

Hepatocellular carcinoma in Honduras (2014–2023): nationwide trends in hospital discharges and mortality

AuthorsLarissa Acosta Salgado; Daniela Sofia Cruz Betanco; Gisela Pattarone; Zonia Reyes

AffiliationsDepartment of Molecular Biology, Galileo University, Guatemala City, Guatemala; Fundación Hondureña para la Salud Hepática (FUNHEPA), Tegucigalpa, Honduras; Salud Analytics, Buenos Aires, Argentina; Facultad de Postgrado, Universidad Tecnológica Centroamericana (UNITEC), Tegucigalpa, Honduras

Source PDF DOI Publisher page
102 days

Trends of metabolic dysfunction-associated steatotic liver disease in Mexico, 1990–2023: insights from the Global Burden of disease study

AuthorsIsrael Rico-Alba; Alberto Retana-Guzmán; Marcela Agudelo-Botero; Claudio Alberto Dávila-Cervantes

AffiliationsStrategic Market Access, Novo Nordisk, Mexico City, Mexico; Centro de Investigación en Políticas, Población y Salud, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City, Mexico; Facultad Latinoamericana de Ciencias Sociales, Mexico City, Mexico

Source PDF DOI Publisher page
65 days

The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease

AuthorsFuyi Ma; Huanyu Wang; Kang Wan; Yuan Li; Yuhang Chen; Ru Wang

AffiliationsSchool of Exercise and Health, Shanghai University of Sport, Shanghai, China; School of Physical Education, Shanghai University of Sport, Shanghai, China

Source PDF DOI Publisher page
63 days

The global academic hepatology capacity index (GAHCI): a multi-source assessment reveals profound disparities across Latin America

AuthorsPablo Coste; Ezequiel Ridruejo; Luis Antonio Díaz; Juan Pablo Arab; Mario Pessoa; Nelia Hernández; Marco Arrese

AffiliationsSección de Hepatología, Hospital Rafael Ángel Calderón Guardia, Liver Lab CR, San José, Costa Rica; Sección de Hepatología, Departamento de Medicina, Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC), Buenos Aires, Argentina; Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile; MASLD Research Center, Division of Gastroenterology and Hepatology, University of California, San Diego, San Diego, California, USA; Division of Gastroenterology, Hepatology, and Nutrition, Department of Internal Medicine, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA; Gastroenterology Department, Hospital das Clínicas (LIM07) HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brasil; Gastroenterology and Hepatology Department, Hospital de Clínicas, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay

Source PDF DOI Publisher page
83 days

Nationwide analysis on the impact of the organization of care on the outcomes of perihilar cholangiocarcinoma

AuthorsMerve Rousian; Julien A. Luyten; Lydia van der Geest; Stefan Buttner; Maxime Dewulf; Lydi M.W.J. van Driel; Joris Erdmann; Dries Braat; Robert J. Porte; Joanne Verheij; Judith de Vos-Geelen; Bas Groot Koerkamp; Pim B. Olthof

AffiliationsDepartment of Surgery, Division of HPB and transplantation surgery, Erasmus MC Cancer Institute, Rotterdam, Netherlands; Department of Surgery, Maastricht University Medical Center, Maastricht, Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht & Department of Medical Oncology, Amsterdam University Medical Center, Amsterdam, Netherlands; Department of gastroenterology, Erasmus MC Cancer Institute, Rotterdam, Netherlands; Department of Surgery, Amsterdam University Medical Center, Amsterdam, Netherlands; Department of Surgery, Leiden University Medical Center, Leiden, Netherlands; Department of Pathology, Amsterdam University Medical Center, Amsterdam, Netherlands; Department of Internal Medicine, Division of Medical Oncology, GROW – Research Institute for Oncology & Reproduction, Maastricht University Medical Centre, Maastricht, Netherlands

Source PDF DOI Publisher page
80 days

Association of nonselective β blockers with the development of hepatocellular carcinoma in liver cirrhosis: a meta-analysis

AuthorsYan Xu; Xiaohe Wang; Xiangdong Li; Qingchun Zhao; Xiangbo Xu

AffiliationsDepartment of Clinical Pharmacy, General Hospital of Northern Theater Command, Shenyang, China; Department of Clinical Pharmacy, Shenyang Pharmaceutical University, Shenyang, China; Department of Medical Records, the Second Hospital of Chifeng City, Chifeng, China

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.